About Corneal Cross-Linking
To maintain the shape and strength of the cornea, our award-winning team at Vance Thompson Vision may advise corneal cross-linking to patients who present moderate to severe corneal thinning and/or keratoconus. Our doctors are committed to creating and protecting your vision, and they are delighted to offer corneal cross-linking as it was recently approved by the FDA. Vance Thompson Vision has been involved with corneal cross-linking since 2011 through our participation in the clinical trials leading up to FDA approval. We are now implementing this exciting technology and eager to continue developing and researching this treatment. At our office in Bozeman, MT, we see men and women with advanced cases of irregularly shaped corneas, also known as ectasia, and we look forward to treating these patients as soon as possible.
Corneal cross-linking, also known as CXL, is implemented to slow the progression of ectasia. CXL will not restore the cornea to its initial shape or correct poor vision. In treatment, we use a combination of ultraviolet light and riboflavin to form additional cross-links within the insufficiencies of the cornea.
What is ectasia? Patients who have ectasia experience a bulging and protrusion of their cornea in a cone-like shape. At some point, the cornea will start to lose its strength since it is stretched beyond standard means. Vision in patients with ectasia will weaken as the cornea progressively weakens as well.
"Professional, efficient, friendly, and compassionate"- A.V. / Google / Jun 29, 2019
"Had a great impression on staff and Doctors. Very helpful and answered all my questions that were asked. They are a professional team."- L.L. / Facebook / Jun 29, 2019
"I had an excellent experience. Bree was very professional with all of my testing. I appreciated the guidance that Dr. Swan gave me regarding my eyes ."- S.F. / Google / Jun 25, 2019
"Best staff and care on earth!"- T.B. / Facebook / Jun 19, 2019
"Everyone was very friendly and thorough. I only have to do one eye drop once a day. Never had any pain."- B.J. / Facebook / Jun 19, 2019
An ideal candidate for CXL will have a diagnosis of ectasia, keratoconus, pellucid marginal degeneration, and any other disorder or disease that will lead to the thinning of the cornea. Patients with blurred or distorted vision, chronic eye irritation, or glare/light sensitivities may also be referred to our practice for a consultation as these conditions can be symptomatic of something wrong with the cornea.
While CXL is not a surgical procedure, it is still referred to as a minimally invasive treatment. During your diagnostic testing, your corneas will be mapped to detect deterioration and the level of severity of your condition. When you come into our office for your CXL procedure, you will lie on your back with an eye held open (one at a time) for the treatment. Riboflavin drops will be added to the eye while you are under ultraviolet light.
Advanced cases of ectasia will require the removal of the epithelium layer of the cornea to allow the liquid riboflavin to infiltrate within the corneal tissue. During treatment planning, your surgeon will discuss all your options for strengthening your cornea and how to manage your eye condition in the future, as CXL can be combined with other procedures for a more comprehensive treatment.
What to Expect
Your post-procedure aftercare is very important to your treatment. Please schedule and keep all follow-up appointments with your eye care provider. You should watch for excessive swelling, irritation, pain, and/or infection in your eyes. Call our office immediately if you experience these symptoms.
- Recovery Time
- 3 - 4 days
- Procedure Time
- 1.5 hours
- Follow Up Time
- 3 days, 2 weeks, 1 month
- Recovery Location
Get Connected To Us
Having this sight-saving procedure may eliminate your need for a corneal transplant in the future. We invite you to connect with Vance Thompson Vision to learn more about how CXL can slow your progressive keratoconus or ectasis. Schedule your consultation today.